Serum uromodulin predicts graft failure in renal transplant recipients

Dominik Steubl, Matthias Block, Victor Herbst, Wolfgang Schlumberger, Andreas Nockher, Susanne Angermann, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Jürgen Scherberich

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Objective and methods: Test the ability of serum uromodulin concentrations 1–3 months after renal transplantation to predict all-cause mortality (ACM) and graft loss (GL) in 91 patients. Results: uromodulin predicted GL equivalently to the other markers studied: the risk for GL was reduced by 0.21 per one standard deviation (SD) increase (cystatin C: hazard ratio [HR] 4.57, creatinine: HR 4.53, blood-urea-nitrogen [BUN]: HR 2.50, estimated glomerular filtration rate [eGFR]: HR 0.10). In receiver-operating-characteristic (ROC) analysis, uromodulin predicted GL with an area-under-the curve of 0.782 at an optimal cut-off (OCO) of 24.0 ng/ml with a sensitivity of 90.0% and a specificity of 70.2%. Conclusion: Serum uromodulin predicted GL equivalently compared to conventional biomarkers of glomerular filtration.

Original languageEnglish
Pages (from-to)171-177
Number of pages7
JournalBiomarkers
Volume22
Issue number2
DOIs
StatePublished - 17 Feb 2017

Keywords

  • Biomarker
  • Tamm–Horsfall protein
  • cystatin C
  • eGFR
  • graft failure
  • kidney transplantation
  • proteinuria
  • uromodulin

Fingerprint

Dive into the research topics of 'Serum uromodulin predicts graft failure in renal transplant recipients'. Together they form a unique fingerprint.

Cite this